Menu Back toA Case Study : History of Expedited Development of Regkirona inj (Regdanvimab)

NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations

The timing is as per Korean Time Zone


A Case Study : History of Expedited Development of Regkirona inj (Regdanvimab)

Speaker(s)

Min Soo  Kim

Min Soo Kim

  • Director, Head of Cell Science Department, Research & Development
  • Celltrion, Korea, Republic of

Contact us

Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574